{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:10:42Z","timestamp":1790053842535,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["172654"],"award-info":[{"award-number":["172654"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012171","name":"Ontario Research Foundation","doi-asserted-by":"publisher","award":["C-097-2425756-STEWART"],"award-info":[{"award-number":["C-097-2425756-STEWART"]}],"id":[{"id":"10.13039\/100012171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.stemcr.2026.102854","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:46:28Z","timestamp":1773326788000},"page":"102854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials"],"prefix":"10.1016","volume":"21","author":[{"given":"Shane W.","family":"English","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Mathew","family":"Lalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Courtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Watpool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josee","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hodgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Th\u00e9baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Chass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius A.","family":"M\u00f6bius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-8691","authenticated-orcid":false,"given":"Duncan J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2026.102854_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211024942","article-title":"The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial","volume":"30","author":"Adas","year":"2021","journal-title":"Cell Transplant."},{"key":"10.1016\/j.stemcr.2026.102854_bib2","first-page":"E71","article-title":"Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use","volume":"23","author":"Atluri","year":"2020","journal-title":"Pain Physician"},{"key":"10.1016\/j.stemcr.2026.102854_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/rme.13.91","article-title":"Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: implications for cell retention at physiologic sites","volume":"9","author":"Bain","year":"2014","journal-title":"Regen. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.stemcr.2026.102854_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.202201-0157OC","article-title":"A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19","volume":"207","author":"Bowdish","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib7","article-title":"The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome","volume":"12","author":"Cesta","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.stemcr.2026.102854_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stemcr.2026.102854_bib9","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFN\u03b3 Licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2026.102854_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s40778-022-00212-1","article-title":"Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal\/Stem Cells and Other Common Cellular Therapeutics","volume":"8","author":"Cottle","year":"2022","journal-title":"Curr. Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2026.102854_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953502","article-title":"Low baseline IFN-\u03b3 response could predict hospitalization in COVID-19 patients","volume":"13","author":"Cremoni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stemcr.2026.102854_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102854_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/rccm.202311-2046CP","article-title":"Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?","volume":"209","author":"Curley","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75053","article-title":"Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review","volume":"11","author":"Dave","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.stemcr.2026.102854_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.15171\/apb.2015.021","article-title":"The Effect of Hypoxia on Mesenchymal Stem Cell Biology","volume":"5","author":"Ejtehadifar","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.stemcr.2026.102854_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-019-1452-1","article-title":"The role of pulmonary mesenchymal cells in airway epithelium regeneration during injury repair","volume":"10","author":"Fang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-\u03b3 licensing","volume":"14","author":"Fran\u00e7ois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.stemcr.2026.102854_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102854_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.202302-0297OC","article-title":"Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial","volume":"208","author":"Gorman","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib21","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1038\/s41467-023-43447-0","article-title":"Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2","volume":"14","author":"Hilligan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2026.102854_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585647","article-title":"Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stemcr.2026.102854_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow\u2013derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib24","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2026.102854_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","article-title":"Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial","volume":"13","author":"Kaffash Farkhad","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41598-020-79664-6","article-title":"Interferon-\u03b3 enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis","volume":"11","author":"Kanai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2026.102854_bib27","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.36076\/ppj.2020\/23\/S421","article-title":"Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19","volume":"23","author":"Kaye","year":"2020","journal-title":"Pain Physician"},{"key":"10.1016\/j.stemcr.2026.102854_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","article-title":"Role for Interferon-\u03b3 in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells","volume":"24","author":"Krampera","year":"2006","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2026.102854_bib29","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2026.102854_bib30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib31","series-title":"Nonparametrics: Statistical Methods Based on Ranks","author":"Lehmann","year":"2006"},{"key":"10.1016\/j.stemcr.2026.102854_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.stemcr.2026.102854_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biom14010008","article-title":"Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities","volume":"14","author":"Le\u00f3n-Moreno","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.stemcr.2026.102854_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stemcr.2026.102854_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.stemcr.2026.102854_bib36","article-title":"Immunomodulation and Regenerative Capacity of MSCs for Long-COVID","volume":"22","author":"Loke","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.stemcr.2026.102854_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41409-024-02230-5","article-title":"Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial","volume":"59","author":"Mart\u00ednez-Mu\u00f1oz","year":"2024","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.stemcr.2026.102854_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib39","article-title":"Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)","author":"Matthay","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib40","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","article-title":"Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin","volume":"4","author":"Mei","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.imlet.2015.05.020","article-title":"Mesenchymal stem cells and infectious diseases: Smarter than drugs","volume":"168","author":"Mezey","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.stemcr.2026.102854_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13054-022-03930-4","article-title":"Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial","volume":"26","author":"Monsel","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.stemcr.2026.102854_bib44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102854_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13287-018-0936-8","article-title":"Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine","volume":"9","author":"Netsch","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1164\/rccm.202003-0741ED","article-title":"Rising to the challenge of CovID-19: Advice for pulmonary and critical care and an agenda for research","volume":"201","author":"Niederman","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1224865","article-title":"Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial","volume":"10","author":"Pochon","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib48","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal subjects","volume":"322","author":"van der Poll","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1513\/AnnalsATS.201811-843PS","article-title":"Multipotent mesenchymal stromal cells and lung disease: Not ready for prime time","volume":"16","author":"Purdon","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.stemcr.2026.102854_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-022-02796-1","article-title":"Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial","volume":"13","author":"Rebelatto","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib51","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.stemcr.2026.102854_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12964-024-01718-3","article-title":"SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147","volume":"22","author":"Shouman","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.stemcr.2026.102854_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: A clinical\u2013therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.stemcr.2026.102854_bib55","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1634\/stemcells.2007-1122","article-title":"In Search of the In Vivo Identity of Mesenchymal Stem Cells","volume":"26","author":"da Silva Meirelles","year":"2008","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2026.102854_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39268-2","article-title":"Effectiveness and safety of normoxic allogenic umbilical cord mesenchymal stem cells administered as adjunctive treatment in patients with severe COVID-19","volume":"13","author":"Soetjahjo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2026.102854_bib57","article-title":"MSC Therapy for ARDS: End of the Line or a Bump in the Road?","author":"Stewart","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.stemcr.2026.102854_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.stemcr.2026.102854_bib59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2326-6066.CIR-14-0022","article-title":"The biology and medical implications of interleukin-6","volume":"2","author":"Tanaka","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.stemcr.2026.102854_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.stemcr.2026.102854_bib61","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jcyt.2018.02.146","article-title":"Safety of cell therapy with mesenchymal stromal cells): An updated systematic review and meta-analysis of randomized controlled trials (SafeCell update)","volume":"20","author":"Thomspon","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.stemcr.2026.102854_bib62","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.stemcr.2026.102854_bib63","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3389\/fimmu.2019.01228","article-title":"The Necrobiology of Mesenchymal Stromal Cells Affects Therapeutic Efficacy","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stemcr.2026.102854_bib64","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2026.102854_bib65","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/ten.teb.2021.0145","article-title":"Hypoxia-Conditioned Mesenchymal Stem Cells in Tissue Regeneration Application","volume":"28","author":"Yang","year":"2022","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.stemcr.2026.102854_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltab015","article-title":"Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact","volume":"1","author":"Zhang","year":"2021","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.stemcr.2026.102854_bib67","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41422-021-00573-y","article-title":"Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms","volume":"31","author":"Zhu","year":"2021","journal-title":"Cell Res."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:22:11Z","timestamp":1778858531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671126000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213671126000652"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102854","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Stem Cell Research.","name":"copyright","label":"Copyright"}],"article-number":"102854"}}